SecBot SecBot
Insider Cluster (2 insiders) ·Filed Nov 5, 2026

LH

LABCORP HOLDINGS INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed11d 15h ago
Insider cluster: 2 insiders, $498K total
Actionable Insight • Neutral

Insider sales are immaterial in size and do not signal concern. Director Parham's sale without a plan is the only notable element, but the dollar amount is too small to be informative. Monitor next 10-Q for any change in insider selling patterns.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$363.30
T+0 close · Nov 5, 2026 · via day close
Latest settled
+2.48%
T+5 · $372.32
Vs SPY
−0.81%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $363.30entry
  2. T+1 · 11d ago +0.90%α +0.59% · $366.57
  3. T+5 · 5d ago +2.48%α −0.81% · $372.32
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders at Labcorp sold shares in the week following strong Q3 earnings and raised guidance. Director Parham sold $389K open-market without a 10b5-1 plan, while EVP Vaughn sold $108K under a 10b5-1 plan. Total sales of $498K represent 0.0017% of market cap, a trivial amount.

Key Financial Metrics

Direction
selling
Total Value
$498.0K
Insiders
2

Key Facts

  • Director Parham sold 1,078 shares open-market on 2026-10-30 at $361.22, total $389K, no 10b5-1 plan
  • EVP Vaughn sold 306 shares open-market on 2026-11-03 at $353.70, total $108K, under 10b5-1 plan
  • Total open-market sales of $498K represent 0.0017% of Labcorp's $28.7B market cap
  • Sales occurred 2-6 days after Q3 earnings beat and guidance raise

Financial Impact

Total insider sales of $498K, trivial relative to $28.7B market cap

Risk Factors

  • Director Parham's sale without a 10b5-1 plan could be opportunistic, but the $389K amount is negligible for a $28.7B company

Market Snapshot

Exchange
NYSE
Sector
Services-Medical Laboratories
Analyst Consensus
78% bullish (27 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-LH-1793883654935

Track record

29 reports on LH

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +17.60% at T+60 after the Apr 30, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $372.32 Now $372.46 +0.04% settles Nov 19
  2. Nov 10, 20266d ago 144 Neutral 2/10 Entry $372.23 Now $372.46 +0.06% settles Nov 18
  3. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Viewing Entry $363.30 to $372.32 Now $372.46 +2.52% ▲ +2.48% −0.81% vs SPY
  4. Nov 4, 202612d ago 144 Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
  5. Nov 4, 202612d ago 8-K Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
  6. Nov 3, 202613d ago 144 Neutral 2/10 Entry $353.92 to $370.88 Now $372.46 +5.24% ▲ +4.79% +5.38% vs SPY
  7. Oct 30, 202617d ago 144 Neutral 2/10 Entry $361.39 to $366.57 Now $372.46 +3.06% ▲ +1.43% +4.14% vs SPY
  8. Oct 28, 202619d ago 8-K Bullish 6/10 Entry $360.25 to $367.79 Now $372.46 +3.39% ▲ +2.09% +2.81% vs SPY
  9. Oct 26, 202621d ago Institutional Cluster Neutral 3/10 Entry $329.90 to $361.39 Now $372.46 +12.90% ▲ +9.55% +10.81% vs SPY
  10. Oct 21, 202626d ago 8-K Neutral 2/10 Entry $323.75 to $331.17 Now $372.46 +15.05% ▲ +2.29% +2.74% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens Wed (10h 19m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026